Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPA1 related single stranded DNA binding protein, X-linked (RADX) is a nuclear, single-stranded DNA-binding protein recruited to replication forks where it plays a critical role in the maintenance of genome stability by antagonizing the accumulation of RAD51 to prevent excessive homologous recombination. RADX’s function is essential for balancing fork remodeling and protection, minimizing the risk of replication fork collapse, but it does so without inhibiting the cell’s capacity to complete homologous recombination when repair of double-strand breaks is necessary. Mutations in RADX are associated with rare diseases including Mirror Movements 1 and Schimke immunoosseous dysplasia. It is not generally considered a therapeutic target such as a receptor, channel, or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RPA1 related single stranded DNA binding protein, X-linked (RADX).